BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2012
View Archived Issues
Novel acetyl-CoA carboxylase 2 inhibitors presented
Read More
Taisho reports novel phosphodiesterase 10A inhibitors
Read More
Janssen discloses new serotonin 5-HT2B receptor antagonists
Read More
Data presented from TRACER and TRAP2P-TIMI 50 vorapaxar trials
Read More
Immunotherapy potently reduces LDL cholesterol in phase I trials
Read More
Transient receptor potential TRPV1 channel antagonist well tolerated in healthy volunteers
Read More
PharmaNeuroBoost clear to commence proof-of-concept PNB-02 trial
Read More
Omadacycline noninferior to linezolid in phase III trial
Read More
Shionogi and OncoTherapy Science expand licensing agreement
Read More
Allergan obtains rights for Ameluz in Spain
Read More
ImmunoGen begins phase II IMGN-901 study
Read More
Preclinical data support entry of ABTL-0812 into the clinic
Read More
ViroMed clear to conduct head-to-head phase III VM-501 study
Read More
Roche reports topline data from phase III EMILIA trial
Read More
TH-302 gets orphan drug status in E.U. and U.S.
Read More
Myriad Genetics and Cephalon enter agreement for mutation testing in phase I/II study
Read More
Cardium Therapeutics launches wound care product in U.S.
Read More
Portola begins pivotal study of its factor Xa inhibitor
Read More
Kyowa Hakko Kirin files application for approval of Parkinson's disease treatment in Japan
Read More
Roche divulges novel HDL cholesterol-increasing agents
Read More
Novel GCS activators patented by Bayer Schering
Read More
First three phase III QVA-149 studies meet primary endpoints
Read More
GSK seeks Japanese approval for combination tablet to prevent and treat malaria
Read More
Minophagen granted additional rights to bexarotene
Read More
Novartis seeks approval for Lucentis line extension
Read More